Serum adhesion molecule levels as prognostic markers in patients with early systemic sclerosis: a multicentre, prospective, observational study.

OBJECTIVE: To assess the utility of circulating adhesion molecule levels as a prognostic indicator of disease progression in systemic sclerosis (SSc) patients with early onset disease. METHODS: Ninety-two Japanese patients with early onset SSc presenting with diffuse skin sclerosis and/or interstiti...

Full description

Bibliographic Details
Main Authors: Minoru Hasegawa, Yoshihide Asano, Hirahito Endo, Manabu Fujimoto, Daisuke Goto, Hironobu Ihn, Katsumi Inoue, Osamu Ishikawa, Yasushi Kawaguchi, Masataka Kuwana, Fumihide Ogawa, Hiroki Takahashi, Sumiaki Tanaka, Shinichi Sato, Kazuhiko Takehara
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2014-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC3916412?pdf=render
id doaj-efb00b1987674d529350fb02fc1f72c2
record_format Article
spelling doaj-efb00b1987674d529350fb02fc1f72c22020-11-24T21:51:08ZengPublic Library of Science (PLoS)PLoS ONE1932-62032014-01-0192e8815010.1371/journal.pone.0088150Serum adhesion molecule levels as prognostic markers in patients with early systemic sclerosis: a multicentre, prospective, observational study.Minoru HasegawaYoshihide AsanoHirahito EndoManabu FujimotoDaisuke GotoHironobu IhnKatsumi InoueOsamu IshikawaYasushi KawaguchiMasataka KuwanaFumihide OgawaHiroki TakahashiSumiaki TanakaShinichi SatoKazuhiko TakeharaOBJECTIVE: To assess the utility of circulating adhesion molecule levels as a prognostic indicator of disease progression in systemic sclerosis (SSc) patients with early onset disease. METHODS: Ninety-two Japanese patients with early onset SSc presenting with diffuse skin sclerosis and/or interstitial lung disease were registered in a multicentre, observational study. Concentrations of intercellular adhesion molecule (ICAM) -1, E-selectin, L-selectin, and P-selectin in serum samples from all patients were measured by enzyme-linked immunosorbent asssay (ELISA). In 39 patients, adhesion molecule levels were measured each year for four years. The ability of baseline adhesion molecule levels to predict subsequent progression and severity in clinical and laboratory features were evaluated statistically. RESULTS: At their first visit, serum levels of ICAM-1, E-selection, P-selectin were significantly elevated and serum L-selectin levels were significantly reduced in patients with SSc compared with healthy controls. Overall, serum ICAM-1 levels at each time point were significantly inversely associated with the %vital capacity (VC) of the same time and subsequent years by univariate analysis. The initial serum ICAM-1 levels were significantly inversely associated with the %VC at the fourth year by multiple regression analysis. The initial serum P-selectin levels were significantly associated with the health assessment questionnaire disability index (HAQ-DI) at the fourth year by multiple regression analysis. Initial adhesion molecule levels were not significantly associated with other clinical features including skin thickness score. Baseline adhesion molecule levels were not significantly associated with subsequent rate of change of clinical parameters. CONCLUSION: In patients with SSc, serum levels of ICAM-1 and P-selectin may serve as prognostic indicators of respiratory dysfunction and physical disability, respectively. Further longitudinal studies of larger populations are needed to confirm these findings.http://europepmc.org/articles/PMC3916412?pdf=render
collection DOAJ
language English
format Article
sources DOAJ
author Minoru Hasegawa
Yoshihide Asano
Hirahito Endo
Manabu Fujimoto
Daisuke Goto
Hironobu Ihn
Katsumi Inoue
Osamu Ishikawa
Yasushi Kawaguchi
Masataka Kuwana
Fumihide Ogawa
Hiroki Takahashi
Sumiaki Tanaka
Shinichi Sato
Kazuhiko Takehara
spellingShingle Minoru Hasegawa
Yoshihide Asano
Hirahito Endo
Manabu Fujimoto
Daisuke Goto
Hironobu Ihn
Katsumi Inoue
Osamu Ishikawa
Yasushi Kawaguchi
Masataka Kuwana
Fumihide Ogawa
Hiroki Takahashi
Sumiaki Tanaka
Shinichi Sato
Kazuhiko Takehara
Serum adhesion molecule levels as prognostic markers in patients with early systemic sclerosis: a multicentre, prospective, observational study.
PLoS ONE
author_facet Minoru Hasegawa
Yoshihide Asano
Hirahito Endo
Manabu Fujimoto
Daisuke Goto
Hironobu Ihn
Katsumi Inoue
Osamu Ishikawa
Yasushi Kawaguchi
Masataka Kuwana
Fumihide Ogawa
Hiroki Takahashi
Sumiaki Tanaka
Shinichi Sato
Kazuhiko Takehara
author_sort Minoru Hasegawa
title Serum adhesion molecule levels as prognostic markers in patients with early systemic sclerosis: a multicentre, prospective, observational study.
title_short Serum adhesion molecule levels as prognostic markers in patients with early systemic sclerosis: a multicentre, prospective, observational study.
title_full Serum adhesion molecule levels as prognostic markers in patients with early systemic sclerosis: a multicentre, prospective, observational study.
title_fullStr Serum adhesion molecule levels as prognostic markers in patients with early systemic sclerosis: a multicentre, prospective, observational study.
title_full_unstemmed Serum adhesion molecule levels as prognostic markers in patients with early systemic sclerosis: a multicentre, prospective, observational study.
title_sort serum adhesion molecule levels as prognostic markers in patients with early systemic sclerosis: a multicentre, prospective, observational study.
publisher Public Library of Science (PLoS)
series PLoS ONE
issn 1932-6203
publishDate 2014-01-01
description OBJECTIVE: To assess the utility of circulating adhesion molecule levels as a prognostic indicator of disease progression in systemic sclerosis (SSc) patients with early onset disease. METHODS: Ninety-two Japanese patients with early onset SSc presenting with diffuse skin sclerosis and/or interstitial lung disease were registered in a multicentre, observational study. Concentrations of intercellular adhesion molecule (ICAM) -1, E-selectin, L-selectin, and P-selectin in serum samples from all patients were measured by enzyme-linked immunosorbent asssay (ELISA). In 39 patients, adhesion molecule levels were measured each year for four years. The ability of baseline adhesion molecule levels to predict subsequent progression and severity in clinical and laboratory features were evaluated statistically. RESULTS: At their first visit, serum levels of ICAM-1, E-selection, P-selectin were significantly elevated and serum L-selectin levels were significantly reduced in patients with SSc compared with healthy controls. Overall, serum ICAM-1 levels at each time point were significantly inversely associated with the %vital capacity (VC) of the same time and subsequent years by univariate analysis. The initial serum ICAM-1 levels were significantly inversely associated with the %VC at the fourth year by multiple regression analysis. The initial serum P-selectin levels were significantly associated with the health assessment questionnaire disability index (HAQ-DI) at the fourth year by multiple regression analysis. Initial adhesion molecule levels were not significantly associated with other clinical features including skin thickness score. Baseline adhesion molecule levels were not significantly associated with subsequent rate of change of clinical parameters. CONCLUSION: In patients with SSc, serum levels of ICAM-1 and P-selectin may serve as prognostic indicators of respiratory dysfunction and physical disability, respectively. Further longitudinal studies of larger populations are needed to confirm these findings.
url http://europepmc.org/articles/PMC3916412?pdf=render
work_keys_str_mv AT minoruhasegawa serumadhesionmoleculelevelsasprognosticmarkersinpatientswithearlysystemicsclerosisamulticentreprospectiveobservationalstudy
AT yoshihideasano serumadhesionmoleculelevelsasprognosticmarkersinpatientswithearlysystemicsclerosisamulticentreprospectiveobservationalstudy
AT hirahitoendo serumadhesionmoleculelevelsasprognosticmarkersinpatientswithearlysystemicsclerosisamulticentreprospectiveobservationalstudy
AT manabufujimoto serumadhesionmoleculelevelsasprognosticmarkersinpatientswithearlysystemicsclerosisamulticentreprospectiveobservationalstudy
AT daisukegoto serumadhesionmoleculelevelsasprognosticmarkersinpatientswithearlysystemicsclerosisamulticentreprospectiveobservationalstudy
AT hironobuihn serumadhesionmoleculelevelsasprognosticmarkersinpatientswithearlysystemicsclerosisamulticentreprospectiveobservationalstudy
AT katsumiinoue serumadhesionmoleculelevelsasprognosticmarkersinpatientswithearlysystemicsclerosisamulticentreprospectiveobservationalstudy
AT osamuishikawa serumadhesionmoleculelevelsasprognosticmarkersinpatientswithearlysystemicsclerosisamulticentreprospectiveobservationalstudy
AT yasushikawaguchi serumadhesionmoleculelevelsasprognosticmarkersinpatientswithearlysystemicsclerosisamulticentreprospectiveobservationalstudy
AT masatakakuwana serumadhesionmoleculelevelsasprognosticmarkersinpatientswithearlysystemicsclerosisamulticentreprospectiveobservationalstudy
AT fumihideogawa serumadhesionmoleculelevelsasprognosticmarkersinpatientswithearlysystemicsclerosisamulticentreprospectiveobservationalstudy
AT hirokitakahashi serumadhesionmoleculelevelsasprognosticmarkersinpatientswithearlysystemicsclerosisamulticentreprospectiveobservationalstudy
AT sumiakitanaka serumadhesionmoleculelevelsasprognosticmarkersinpatientswithearlysystemicsclerosisamulticentreprospectiveobservationalstudy
AT shinichisato serumadhesionmoleculelevelsasprognosticmarkersinpatientswithearlysystemicsclerosisamulticentreprospectiveobservationalstudy
AT kazuhikotakehara serumadhesionmoleculelevelsasprognosticmarkersinpatientswithearlysystemicsclerosisamulticentreprospectiveobservationalstudy
_version_ 1725880175310143488